Dr. Reddy's Laboratories’ wholly-owned step-down subsidiary -- Dr. Reddy’s Laboratories, Inc. is recalling 1,03,298 bottles (800 mg); 31,802 bottles (600 mg); and 14,940 bottles (400 mg) of Ibuprofen tablets in the US market. The company is recalling the affected lot due to ‘Failed impurities/degradation specifications’. Results for unknown impurity were 0.13 per cent and 0.11 per cent, respectively, exceeding the 0.10 per cent specification limit. The company initiated the Class II nationwide recall on August 6, 2024.
Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.
